{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T03:30:36Z","timestamp":1792467036620,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T00:00:00Z","timestamp":1599782400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T00:00:00Z","timestamp":1599782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s10875-020-00862-y","type":"journal-article","created":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T20:02:44Z","timestamp":1599854564000},"page":"1138-1143","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Long-Term Survival after Progressive Multifocal Leukoencephalopathy in a Patient with Primary Immune Deficiency and NFKB1 Mutation"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6894-7725","authenticated-orcid":false,"given":"Emke","family":"Mar\u00e9chal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolien","family":"Beel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roel","family":"Crols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Hernalsteen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Willekens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,11]]},"reference":[{"issue":"4","key":"862_CR1","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/j.jaci.2018.01.039","volume":"142","author":"P Tuijnenburg","year":"2018","unstructured":"Tuijnenburg P, Lango Allen H, Burns SO, Greene D, Jansen MH, Staples E, et al. Loss-of-function nuclear factor kappaB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans. J Allergy Clin Immunol. 2018;142(4):1285\u201396.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"862_CR2","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.ncl.2008.03.007","volume":"26","author":"T Weber","year":"2008","unstructured":"Weber T. Progressive multifocal leukoencephalopathy. Neurol Clin. 2008;26(3):833\u201354 x-xi.","journal-title":"Neurol Clin"},{"issue":"11","key":"862_CR3","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1136\/jnnp.2009.179002","volume":"81","author":"MA Lima","year":"2010","unstructured":"Lima MA, Bernal-Cano F, Clifford DB, Gandhi RT, Koralnik IJ. Clinical outcome of long-term survivors of progressive multifocal leukoencephalopathy. J Neurol Neurosurg Psychiatry. 2010;81(11):1288\u201391.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"862_CR4","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1212\/01.WNL.0000160385.43633.34","volume":"64","author":"MD Snyder","year":"2005","unstructured":"Snyder MD, Storch GA, Clifford DB. Atypical PML leading to a diagnosis of common variable immunodeficiency. Neurology. 2005;64(9):1661.","journal-title":"Neurology."},{"key":"862_CR5","unstructured":"Guffroy A, Ruch Y, Dieudonne Y, Kienny A, Gavand PE, Poindron V, et al. Progressive multifocal leukoencephalopathy (PML) in patients with common variable immunodeficiency (CVID): description of two cases associated with CD8+ lymphoproliferation2016."},{"issue":"1","key":"862_CR6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s10875-018-0578-8","volume":"39","author":"J Hadjadj","year":"2019","unstructured":"Hadjadj J, Guffroy A, Delavaud C, Taieb G, Meyts I, Fresard A, et al. Progressive multifocal leukoencephalopathy in primary Immunodeficiencies. J Clin Immunol. 2019;39(1):55\u201364.","journal-title":"J Clin Immunol"},{"issue":"3","key":"862_CR7","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.immuni.2019.02.003","volume":"50","author":"JM Lindner","year":"2019","unstructured":"Lindner JM, Cornacchione V, Sathe A, Be C, Srinivas H, Riquet E, et al. Human memory B cells harbor diverse cross-neutralizing antibodies against BK and JC polyomaviruses. Immunity. 2019;50(3):668\u201376 e5.","journal-title":"Immunity."},{"key":"862_CR8","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3389\/fimmu.2015.00241","volume":"6","author":"D Durali","year":"2015","unstructured":"Durali D, de Goer de Herve MG, Gasnault J, Taoufik Y. B cells and progressive multifocal leukoencephalopathy: search for the missing link. Front Immunol. 2015;6:241.","journal-title":"Front Immunol"},{"issue":"6","key":"862_CR9","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1007\/s13365-015-0340-4","volume":"21","author":"R Kurmann","year":"2015","unstructured":"Kurmann R, Weisstanner C, Kardas P, Hirsch HH, Wiest R, Lammle B, et al. Progressive multifocal leukoencephalopathy in common variable immunodeficiency: mitigated course under mirtazapine and mefloquine. J Neurovirol. 2015;21(6):694\u2013701.","journal-title":"J Neurovirol"},{"issue":"7","key":"862_CR10","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1136\/jcp.45.7.624","volume":"45","author":"SA Misbah","year":"1992","unstructured":"Misbah SA, Spickett GP, Zeman A, Esiri MM, Wallington TB, Kurtz JB, et al. Progressive multifocal leucoencephalopathy, sclerosing cholangitis, bronchiectasis and disseminated warts in a patient with primary combined immune deficiency. J Clin Pathol. 1992;45(7):624\u20137.","journal-title":"J Clin Pathol"},{"issue":"5","key":"862_CR11","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/S1081-1206(10)60764-8","volume":"98","author":"S Narula","year":"2007","unstructured":"Narula S, LaRosa DF, Kamoun M, Dalmau J, Levinson AI. Progressive multifocal leukoencephalopathy in a patient with common variable immunodeficiency and abnormal CD8+ T-cell subset distribution. Ann Allergy Asthma Immunol. 2007;98(5):483\u20139.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"862_CR12","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1086\/517027","volume":"26","author":"PG Scotton","year":"1998","unstructured":"Scotton PG, Vaglia A, Carniato A, Marchiori GC. Progressive multifocal leukoencephalopathy in a patient with common variable immunodeficiency. Clin Infect Dis. 1998;26(1):215\u20136.","journal-title":"Clin Infect Dis"},{"key":"862_CR13","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3389\/fimmu.2016.00220","volume":"7","author":"P Maffucci","year":"2016","unstructured":"Maffucci P, Filion CA, Boisson B, Itan Y, Shang L, Casanova JL, et al. Genetic diagnosis using whole exome sequencing in common variable immunodeficiency. Front Immunol. 2016;7:220.","journal-title":"Front Immunol"},{"issue":"6","key":"862_CR14","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1177\/1756285615602832","volume":"8","author":"D Pavlovic","year":"2015","unstructured":"Pavlovic D, Patera AC, Nyberg F, Gerber M, Liu M. Progressive multifocal leukeoncephalopathy C. Progressive multifocal leukoencephalopathy: current treatment options and future perspectives. Ther Adv Neurol Disord. 2015;8(6):255\u201373.","journal-title":"Ther Adv Neurol Disord"},{"issue":"5","key":"862_CR15","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1007\/s13365-018-0657-x","volume":"24","author":"A Harel","year":"2018","unstructured":"Harel A, Horng S, Gustafson T, Ramineni A, Farber RS, Fabian M. Successful treatment of progressive multifocal leukoencephalopathy with recombinant interleukin-7 and maraviroc in a patient with idiopathic CD4 lymphocytopenia. J Neurovirol. 2018;24(5):652\u20135.","journal-title":"J Neurovirol"},{"key":"862_CR16","doi-asserted-by":"crossref","unstructured":"Cortese I, Muranski P, Enose-Akahata Y, Ha SK, Smith B, Monaco M, et al. Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy. The New England journal of medicine. 2019.","DOI":"10.1056\/NEJMoa1815039"},{"issue":"6","key":"862_CR17","first-page":"242","volume":"113","author":"N Epperla","year":"2014","unstructured":"Epperla N, Medina-Flores R, Mazza JJ, Yale SH. Mirtazapine and mefloquine therapy for non-AIDS-related progressive multifocal leukoencephalopathy. WMJ : official publication of the State Medical Society of Wisconsin. 2014;113(6):242\u20135.","journal-title":"WMJ : official publication of the State Medical Society of Wisconsin"},{"issue":"5700","key":"862_CR18","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1126\/science.1103492","volume":"306","author":"GF Elphick","year":"2004","unstructured":"Elphick GF, Querbes W, Jordan JA, Gee GV, Eash S, Manley K, et al. The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science. 2004;306(5700):1380\u20133.","journal-title":"Science."},{"issue":"2","key":"862_CR19","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1001\/archneurol.2008.557","volume":"66","author":"D Cettomai","year":"2009","unstructured":"Cettomai D, McArthur JC. Mirtazapine use in human immunodeficiency virus-infected patients with progressive multifocal leukoencephalopathy. Arch Neurol. 2009;66(2):255\u20138.","journal-title":"Arch Neurol"},{"issue":"3","key":"862_CR20","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1159\/000333780","volume":"3","author":"JH Park","year":"2011","unstructured":"Park JH, Ryoo S, Noh HJ, Seo JM, Kang HH, Shin JS, et al. Dual therapy with cidofovir and mirtazapine for progressive multifocal leukoencephalopathy in a sarcoidosis patient. Case Rep Neurol. 2011;3(3):258\u201362.","journal-title":"Case Rep Neurol"},{"issue":"5","key":"862_CR21","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1086\/520514","volume":"196","author":"S Verma","year":"2007","unstructured":"Verma S, Cikurel K, Koralnik IJ, Morgello S, Cunningham-Rundles C, Weinstein ZR, et al. Mirtazapine in progressive multifocal leukoencephalopathy associated with polycythemia vera. J Infect Dis. 2007;196(5):709\u201311.","journal-title":"J Infect Dis"},{"issue":"9","key":"862_CR22","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1136\/jnnp.2006.092353","volume":"77","author":"S Vulliemoz","year":"2006","unstructured":"Vulliemoz S, Lurati-Ruiz F, Borruat FX, Delavelle J, Koralnik IJ, Kuntzer T, et al. Favourable outcome of progressive multifocal leucoencephalopathy in two patients with dermatomyositis. J Neurol Neurosurg Psychiatry. 2006;77(9):1079\u201382.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"862_CR23","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1093\/rheumatology\/kem049","volume":"46","author":"K Owczarczyk","year":"2007","unstructured":"Owczarczyk K, Hilker R, Brunn A, Hallek M, Rubbert A. Progressive multifocal leucoencephalopathy in a patient with sarcoidosis--successful treatment with cidofovir and mirtazapine. Rheumatology. 2007;46(5):888\u201390.","journal-title":"Rheumatology."},{"issue":"11","key":"862_CR24","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1001\/archneurol.2010.157","volume":"67","author":"A Schroder","year":"2010","unstructured":"Schroder A, Lee DH, Hellwig K, Lukas C, Linker RA, Gold R. Successful management of natalizumab-associated progressive multifocal leukoencephalopathy and immune reconstitution syndrome in a patient with multiple sclerosis. Arch Neurol. 2010;67(11):1391\u20134.","journal-title":"Arch Neurol"},{"issue":"19","key":"862_CR25","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1212\/WNL.0b013e3181c0d4a1","volume":"73","author":"A Marzocchetti","year":"2009","unstructured":"Marzocchetti A, Tompkins T, Clifford DB, Gandhi RT, Kesari S, Berger JR, et al. Determinants of survival in progressive multifocal leukoencephalopathy. Neurology. 2009;73(19):1551\u20138.","journal-title":"Neurology."},{"issue":"5","key":"862_CR26","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1128\/AAC.01614-08","volume":"53","author":"M Brickelmaier","year":"2009","unstructured":"Brickelmaier M, Lugovskoy A, Kartikeyan R, Reviriego-Mendoza MM, Allaire N, Simon K, et al. Identification and characterization of mefloquine efficacy against JC virus in vitro. Antimicrob Agents Chemother. 2009;53(5):1840\u20139.","journal-title":"Antimicrob Agents Chemother"},{"issue":"14","key":"862_CR27","doi-asserted-by":"publisher","first-page":"7256","DOI":"10.1128\/JVI.02506-10","volume":"85","author":"S Gheuens","year":"2011","unstructured":"Gheuens S, Bord E, Kesari S, Simpson DM, Gandhi RT, Clifford DB, et al. Role of CD4+ and CD8+ T-cell responses against JC virus in the outcome of patients with progressive multifocal leukoencephalopathy (PML) and PML with immune reconstitution inflammatory syndrome. J Virol. 2011;85(14):7256\u201363.","journal-title":"J Virol"},{"issue":"4","key":"862_CR28","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s13365-013-0173-y","volume":"19","author":"DB Clifford","year":"2013","unstructured":"Clifford DB, Nath A, Cinque P, Brew BJ, Zivadinov R, Gorelik L, et al. A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomes. J Neurovirol. 2013;19(4):351\u20138.","journal-title":"J Neurovirol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-020-00862-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-020-00862-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-020-00862-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T23:30:56Z","timestamp":1631316656000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-020-00862-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,11]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["862"],"URL":"https:\/\/doi.org\/10.1007\/s10875-020-00862-y","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,11]]},"assertion":[{"value":"7 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}